Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides

Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2004-05, Vol.343 (1), p.119-127
Hauptverfasser: Valerio, Anna, Basso, Daniela, Fogar, Paola, Falconi, Massimo, Greco, Eliana, Bassi, Claudio, Seraglia, Roberta, Abu-Hilal, Mohamed, Navaglia, Filippo, Zambon, Carlo-Federico, Gallo, Nicoletta, Falda, Alessandra, Pedrazzoli, Sergio, Plebani, Mario
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 127
container_issue 1
container_start_page 119
container_title Clinica chimica acta
container_volume 343
creator Valerio, Anna
Basso, Daniela
Fogar, Paola
Falconi, Massimo
Greco, Eliana
Bassi, Claudio
Seraglia, Roberta
Abu-Hilal, Mohamed
Navaglia, Filippo
Zambon, Carlo-Federico
Gallo, Nicoletta
Falda, Alessandra
Pedrazzoli, Sergio
Plebani, Mario
description Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, to evaluate the peptide composition of PC cell conditioned media (CM) and of portal sera from patients with PC with ( n=7) or without ( n=4) DM. Methods: In liver tissue homogenates of 23 patients with PC ( n=17) or chronic pancreatitis ( n=6) GAPDH mRNA and activity, glucose, lactate, nitrite and nitrate were assayed. MALDI-TOF analysis was performed in three PC cell lines CM, and in portal sera from patients with PC. Results: Higher GAPDH mRNA and nitrite were found in patients with than in patients without DM. In PC cell CM, only 9 among a total of 75 fragments identified, were tumour specific. One hundred seventy-three fragments were identified in the portal sera of patients: one was positively and six fragments were negatively correlated with DM. Conclusions: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM.
doi_str_mv 10.1016/j.cccn.2003.12.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71883713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898104000075</els_id><sourcerecordid>71883713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-ee107b34a8ca77707f8b0a24d5c899d18040b889cac52f2e1085886745657c003</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi1ERbctf4ADyolbgsf5sIO4oIpSpFa9tGfLGU-QV9kk2F6kHvrfmWVXQlw4WON59cxI8wjxDmQFErqP2woR50pJWVegKqngldiA0XVZN716LTZSyr40vYFzcZHSlttGdvBGnEML0Ham3oiXezf5UD4-3BRudtNzCqlYxmJdYnZTkSi6P62bMZLLAQvkL0VOcqA5p09F8FzDGJCTZT7QPriB8vKDZubd7Pnl8E-40soJpStxNrop0dtTvRRPN18fr2_Lu4dv36-_3JVYt00uiUDqoW6cQae1lno0g3Sq8S2avvdg-K7BmB4dtmpUTJvWmE43bddqZD2X4sNx7xqXn3tK2e5CQpomN9OyT1aDMbWGmkF1BDEuKUUa7RrDzsVnC9IepNutPUi3B-kWlGXpPPT-tH0_7Mj_HTlZZuDzESC-8VegaBOyPSQfImG2fgn_2_8bYdKUBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71883713</pqid></control><display><type>article</type><title>Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Valerio, Anna ; Basso, Daniela ; Fogar, Paola ; Falconi, Massimo ; Greco, Eliana ; Bassi, Claudio ; Seraglia, Roberta ; Abu-Hilal, Mohamed ; Navaglia, Filippo ; Zambon, Carlo-Federico ; Gallo, Nicoletta ; Falda, Alessandra ; Pedrazzoli, Sergio ; Plebani, Mario</creator><creatorcontrib>Valerio, Anna ; Basso, Daniela ; Fogar, Paola ; Falconi, Massimo ; Greco, Eliana ; Bassi, Claudio ; Seraglia, Roberta ; Abu-Hilal, Mohamed ; Navaglia, Filippo ; Zambon, Carlo-Federico ; Gallo, Nicoletta ; Falda, Alessandra ; Pedrazzoli, Sergio ; Plebani, Mario</creatorcontrib><description>Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, to evaluate the peptide composition of PC cell conditioned media (CM) and of portal sera from patients with PC with ( n=7) or without ( n=4) DM. Methods: In liver tissue homogenates of 23 patients with PC ( n=17) or chronic pancreatitis ( n=6) GAPDH mRNA and activity, glucose, lactate, nitrite and nitrate were assayed. MALDI-TOF analysis was performed in three PC cell lines CM, and in portal sera from patients with PC. Results: Higher GAPDH mRNA and nitrite were found in patients with than in patients without DM. In PC cell CM, only 9 among a total of 75 fragments identified, were tumour specific. One hundred seventy-three fragments were identified in the portal sera of patients: one was positively and six fragments were negatively correlated with DM. Conclusions: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cccn.2003.12.021</identifier><identifier>PMID: 15115683</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers - analysis ; Cell Line, Tumor ; Cells, Cultured ; Diabetes Complications - blood ; Diabetes Complications - genetics ; Diabetes Complications - metabolism ; Diabetes mellitus ; Female ; Glyceraldehyde-3-Phosphate Dehydrogenases - genetics ; Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism ; Humans ; Liver - enzymology ; Liver - metabolism ; Maldi-TOF ; Male ; Middle Aged ; Nitric oxide ; Nitrites - analysis ; Pancreatic cancer ; Pancreatic Neoplasms - blood ; Pancreatic Neoplasms - complications ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - metabolism ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</subject><ispartof>Clinica chimica acta, 2004-05, Vol.343 (1), p.119-127</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-ee107b34a8ca77707f8b0a24d5c899d18040b889cac52f2e1085886745657c003</citedby><cites>FETCH-LOGICAL-c354t-ee107b34a8ca77707f8b0a24d5c899d18040b889cac52f2e1085886745657c003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0009898104000075$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15115683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valerio, Anna</creatorcontrib><creatorcontrib>Basso, Daniela</creatorcontrib><creatorcontrib>Fogar, Paola</creatorcontrib><creatorcontrib>Falconi, Massimo</creatorcontrib><creatorcontrib>Greco, Eliana</creatorcontrib><creatorcontrib>Bassi, Claudio</creatorcontrib><creatorcontrib>Seraglia, Roberta</creatorcontrib><creatorcontrib>Abu-Hilal, Mohamed</creatorcontrib><creatorcontrib>Navaglia, Filippo</creatorcontrib><creatorcontrib>Zambon, Carlo-Federico</creatorcontrib><creatorcontrib>Gallo, Nicoletta</creatorcontrib><creatorcontrib>Falda, Alessandra</creatorcontrib><creatorcontrib>Pedrazzoli, Sergio</creatorcontrib><creatorcontrib>Plebani, Mario</creatorcontrib><title>Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, to evaluate the peptide composition of PC cell conditioned media (CM) and of portal sera from patients with PC with ( n=7) or without ( n=4) DM. Methods: In liver tissue homogenates of 23 patients with PC ( n=17) or chronic pancreatitis ( n=6) GAPDH mRNA and activity, glucose, lactate, nitrite and nitrate were assayed. MALDI-TOF analysis was performed in three PC cell lines CM, and in portal sera from patients with PC. Results: Higher GAPDH mRNA and nitrite were found in patients with than in patients without DM. In PC cell CM, only 9 among a total of 75 fragments identified, were tumour specific. One hundred seventy-three fragments were identified in the portal sera of patients: one was positively and six fragments were negatively correlated with DM. Conclusions: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - analysis</subject><subject>Cell Line, Tumor</subject><subject>Cells, Cultured</subject><subject>Diabetes Complications - blood</subject><subject>Diabetes Complications - genetics</subject><subject>Diabetes Complications - metabolism</subject><subject>Diabetes mellitus</subject><subject>Female</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - genetics</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</subject><subject>Humans</subject><subject>Liver - enzymology</subject><subject>Liver - metabolism</subject><subject>Maldi-TOF</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nitric oxide</subject><subject>Nitrites - analysis</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - blood</subject><subject>Pancreatic Neoplasms - complications</subject><subject>Pancreatic Neoplasms - genetics</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi1ERbctf4ADyolbgsf5sIO4oIpSpFa9tGfLGU-QV9kk2F6kHvrfmWVXQlw4WON59cxI8wjxDmQFErqP2woR50pJWVegKqngldiA0XVZN716LTZSyr40vYFzcZHSlttGdvBGnEML0Ham3oiXezf5UD4-3BRudtNzCqlYxmJdYnZTkSi6P62bMZLLAQvkL0VOcqA5p09F8FzDGJCTZT7QPriB8vKDZubd7Pnl8E-40soJpStxNrop0dtTvRRPN18fr2_Lu4dv36-_3JVYt00uiUDqoW6cQae1lno0g3Sq8S2avvdg-K7BmB4dtmpUTJvWmE43bddqZD2X4sNx7xqXn3tK2e5CQpomN9OyT1aDMbWGmkF1BDEuKUUa7RrDzsVnC9IepNutPUi3B-kWlGXpPPT-tH0_7Mj_HTlZZuDzESC-8VegaBOyPSQfImG2fgn_2_8bYdKUBQ</recordid><startdate>20040501</startdate><enddate>20040501</enddate><creator>Valerio, Anna</creator><creator>Basso, Daniela</creator><creator>Fogar, Paola</creator><creator>Falconi, Massimo</creator><creator>Greco, Eliana</creator><creator>Bassi, Claudio</creator><creator>Seraglia, Roberta</creator><creator>Abu-Hilal, Mohamed</creator><creator>Navaglia, Filippo</creator><creator>Zambon, Carlo-Federico</creator><creator>Gallo, Nicoletta</creator><creator>Falda, Alessandra</creator><creator>Pedrazzoli, Sergio</creator><creator>Plebani, Mario</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040501</creationdate><title>Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides</title><author>Valerio, Anna ; Basso, Daniela ; Fogar, Paola ; Falconi, Massimo ; Greco, Eliana ; Bassi, Claudio ; Seraglia, Roberta ; Abu-Hilal, Mohamed ; Navaglia, Filippo ; Zambon, Carlo-Federico ; Gallo, Nicoletta ; Falda, Alessandra ; Pedrazzoli, Sergio ; Plebani, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-ee107b34a8ca77707f8b0a24d5c899d18040b889cac52f2e1085886745657c003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - analysis</topic><topic>Cell Line, Tumor</topic><topic>Cells, Cultured</topic><topic>Diabetes Complications - blood</topic><topic>Diabetes Complications - genetics</topic><topic>Diabetes Complications - metabolism</topic><topic>Diabetes mellitus</topic><topic>Female</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - genetics</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</topic><topic>Humans</topic><topic>Liver - enzymology</topic><topic>Liver - metabolism</topic><topic>Maldi-TOF</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nitric oxide</topic><topic>Nitrites - analysis</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - blood</topic><topic>Pancreatic Neoplasms - complications</topic><topic>Pancreatic Neoplasms - genetics</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valerio, Anna</creatorcontrib><creatorcontrib>Basso, Daniela</creatorcontrib><creatorcontrib>Fogar, Paola</creatorcontrib><creatorcontrib>Falconi, Massimo</creatorcontrib><creatorcontrib>Greco, Eliana</creatorcontrib><creatorcontrib>Bassi, Claudio</creatorcontrib><creatorcontrib>Seraglia, Roberta</creatorcontrib><creatorcontrib>Abu-Hilal, Mohamed</creatorcontrib><creatorcontrib>Navaglia, Filippo</creatorcontrib><creatorcontrib>Zambon, Carlo-Federico</creatorcontrib><creatorcontrib>Gallo, Nicoletta</creatorcontrib><creatorcontrib>Falda, Alessandra</creatorcontrib><creatorcontrib>Pedrazzoli, Sergio</creatorcontrib><creatorcontrib>Plebani, Mario</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valerio, Anna</au><au>Basso, Daniela</au><au>Fogar, Paola</au><au>Falconi, Massimo</au><au>Greco, Eliana</au><au>Bassi, Claudio</au><au>Seraglia, Roberta</au><au>Abu-Hilal, Mohamed</au><au>Navaglia, Filippo</au><au>Zambon, Carlo-Federico</au><au>Gallo, Nicoletta</au><au>Falda, Alessandra</au><au>Pedrazzoli, Sergio</au><au>Plebani, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2004-05-01</date><risdate>2004</risdate><volume>343</volume><issue>1</issue><spage>119</spage><epage>127</epage><pages>119-127</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>Background: Pancreatic cancer (PC) associated diabetes mellitus (DM) might be consequent to the diabetogenic effects of tumour products, possibly acting via nitric oxide (NO). Our aims were: (1) to verify whether PC associated DM determines an increased hepatic NO and (2) using MALDI-TOF analysis, to evaluate the peptide composition of PC cell conditioned media (CM) and of portal sera from patients with PC with ( n=7) or without ( n=4) DM. Methods: In liver tissue homogenates of 23 patients with PC ( n=17) or chronic pancreatitis ( n=6) GAPDH mRNA and activity, glucose, lactate, nitrite and nitrate were assayed. MALDI-TOF analysis was performed in three PC cell lines CM, and in portal sera from patients with PC. Results: Higher GAPDH mRNA and nitrite were found in patients with than in patients without DM. In PC cell CM, only 9 among a total of 75 fragments identified, were tumour specific. One hundred seventy-three fragments were identified in the portal sera of patients: one was positively and six fragments were negatively correlated with DM. Conclusions: Unlike liver GAPDH, NO appears to be involved in PC associated DM. In portal sera, the absence, rather than the presence, of specific fragments, appears to be correlated with the development of DM.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>15115683</pmid><doi>10.1016/j.cccn.2003.12.021</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2004-05, Vol.343 (1), p.119-127
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_71883713
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Aged
Aged, 80 and over
Biomarkers - analysis
Cell Line, Tumor
Cells, Cultured
Diabetes Complications - blood
Diabetes Complications - genetics
Diabetes Complications - metabolism
Diabetes mellitus
Female
Glyceraldehyde-3-Phosphate Dehydrogenases - genetics
Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism
Humans
Liver - enzymology
Liver - metabolism
Maldi-TOF
Male
Middle Aged
Nitric oxide
Nitrites - analysis
Pancreatic cancer
Pancreatic Neoplasms - blood
Pancreatic Neoplasms - complications
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
RNA, Messenger - genetics
RNA, Messenger - metabolism
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
title Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A01%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maldi-TOF%20analysis%20of%20portal%20sera%20of%20pancreatic%20cancer%20patients:%20identification%20of%20diabetogenic%20and%20antidiabetogenic%20peptides&rft.jtitle=Clinica%20chimica%20acta&rft.au=Valerio,%20Anna&rft.date=2004-05-01&rft.volume=343&rft.issue=1&rft.spage=119&rft.epage=127&rft.pages=119-127&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cccn.2003.12.021&rft_dat=%3Cproquest_cross%3E71883713%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71883713&rft_id=info:pmid/15115683&rft_els_id=S0009898104000075&rfr_iscdi=true